Funds holding JADE BIOSCIENCES INC
108 funds declare a position · 17 ETFs and 91 other funds · 187.8M $ · US0080642061
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 101 | Russell 2000 Fund Rydex Series Funds | 72 | 1K $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 102 | SMALL-CAP PROFUND ProFunds | 58 | 1.4K $ | 0.02 % | as of Apr 30, 2026 · Original filing |
| 103 | ProShares Hedge Replication ETF ProShares Trust | 47 | 697 $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 104 | Russell 2000 1.5x Strategy Fund Rydex Series Funds | 43 | 604.2 $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 105 | ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 13 | 192.8 $ | 0.02 % | as of Feb 28, 2026 · Original filing |
| 106 | Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 8 | 112.4 $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 107 | Avantis Total Equity Markets ETF American Century ETF Trust | 5 | 74.2 $ | as of Feb 28, 2026 · Original filing | |
| 108 | Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 5 | 70.3 $ | as of Mar 31, 2026 · Original filing |
Institutional managers
113 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 7,085,423 | 99.6M $ | as of Mar 31, 2026 |
| Fairmount Funds Management LLC | 4,553,494 | 64M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 3,671,083 | 51.6M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 3,501,502 | 49.2M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 3,220,364 | 45.2M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 3,105,669 | 43.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,313,949 | 32.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 1,641,137 | 23.1M $ | as of Mar 31, 2026 |
| Remedium Capital Partners, LLC | 1,577,750 | 22.2M $ | as of Mar 31, 2026 |
| Versant Venture Management, LLC | 1,525,820 | 21.4M $ | as of Mar 31, 2026 |
| Avidity Partners Management LP | 1,400,708 | 19.7M $ | as of Mar 31, 2026 |
| SAMSARA BIOCAPITAL, LLC | 968,798 | 13.6M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 964,462 | 13.6M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 944,776 | 13.3M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 867,284 | 12.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 822,520 | 11.6M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 796,744 | 11.2M $ | as of Mar 31, 2026 |
| ACORN CAPITAL ADVISORS, LLC | 786,760 | 11.1M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 655,690 | 9.2M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 639,956 | 9M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 635,498 | 8.9M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 573,205 | 8.1M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 512,349 | 7.2M $ | as of Mar 31, 2026 |
| Opaleye Management Inc. | 427,608 | 6M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 402,489 | 5.7M $ | as of Mar 31, 2026 |